GG 260
Pill imprint GG 260 has been identified as Hydroxychloroquine sulfate 200 mg.
Hydroxychloroquine is used in the treatment of rheumatoid arthritis; systemic lupus erythematosus; sjogren's syndrome; malaria prevention; malaria (and more), and belongs to the drug classes antimalarial quinolines, antirheumatics. FDA has not classified the drug for risk during pregnancy.
Hydroxychloroquine 200 mg is not subject to the Controlled Substances Act.
See also related documents.
Hydroxychloroquine sulfate Images
- Imprint:
-
GG 260
- Strength:
- 200 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- dibasic calcium phosphate
povidone
sodium bicarbonate
magnesium stearate
hydroxypropyl methylcellulose
titanium dioxide
polyethylene glycol
hydroxypropyl cellulose
- Drug Class:
- Antimalarial quinolines
Antirheumatics - Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Sandoz Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00781-1407
More Hydroxychloroquine Sulfate resources
- Hydroxychloroquine (Wolters Kluwer)
- hydroxychloroquine (Cerner Multum)
- hydroxychloroquine (Micromedex) - Includes Dosage Information
- Hydroxychloroquine Sulfate (AHFS DI)
- Hydroxychloroquine Tablets (FDA)
- Hydroxychloroquine Sulfate (Wolters Kluwer)


